missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Fibrillarin Monoclonal Antibody (38F3)

Mouse Monoclonal Antibody
Marque: Invitrogen™ 480009
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Fibrillarin Monoclonal Antibody for ICC/IF, IHC, Western Blot
Nop1p / Fibrillarin was originally identified as a nucleolar protein of bakers yeast, Saccharomyces cerevisiae (accession P15646). The Nop1p protein is essential for yeast viability and is localized in the nucleoli. The human homologue of Nop1p is fibrillarin (accession P22087) a component of the nucleolar small nuclear ribonucleoprotein (snRNP) particle. The human fibrillarin gene is located on chromosome 19 (19q13. 1).
Spécification
| Fibrillarin | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 50% glycerol and 5mM sodium azide | |
| P15646, P22087, P22509, P35550 | |
| fbl, Nop1p | |
| Yeast nuclear preparations. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat, Bovine, Pig, Chicken, Drosophila, Yeast | |
| Antibody | |
| IgG1 |
| Immunohistochemistry, Western Blot, Immunocytochemistry | |
| 38F3 | |
| Unconjugated | |
| fbl | |
| 34 kDa nucleolar scleroderma antigen; 34-kD nucleolar scleroderma antigen; AL022665; AT20009p; CELE_T01C3.7; CG5725; CG5725-PA; CG5725-PB; CG5725-PC; CG5725-PD; CG5725-PE; CG5725-PF; CG5725-PG; Dmel\CG5725; Dmel_CG5725; dPANK; dPANK/Fbl; Fbl; fbl-PA; fbl-PB; fbl-PC; fbl-PD; fbl-PE; fbl-PF; fbl-PG; FIB; FIB1; fib-1; fibrillarin; FLRN; fumble; histone-glutamine methyltransferase; LD24618p; LP11571p; nucleolar protein 1; PANK; pantothenate kinase; RNA, U3 small nucleolar interacting protein 1; RNU3IP1; rRNA 2'-O-methyltransferase fibrillarin; T01C3.7 | |
| Mouse | |
| Protein G | |
| RUO | |
| 100626002, 14113, 2091, 292747, 46234, 538548, 851548 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu